This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of. Active years: 1989-1995.
Company Filing History:
3 out of 1,217 
1 out of 2,202 
Years Active: 1989-1995
Title: Innovations and Contributions of Stanley I Rapoport
Introduction
Stanley I Rapoport is a notable inventor based in Washington, DC, recognized for his significant contributions to the field of cognitive disorders. With a total of 4 patents, Rapoport has focused on developing innovative methods and compounds aimed at improving cognitive health, particularly in relation to aging and Alzheimer's disease.
Latest Patents
Rapoport's latest patents include a method for treating cognitive disorders with phenserine. This invention presents an improved method of cholinomimetic therapy for cognitive impairments associated with aging and Alzheimer's disease. It involves treating a patient with an effective amount of phenserine or a pharmaceutically acceptable salt and derivatives. Another significant patent is for substituted phenserines as specific inhibitors of acetylcholinesterase. This invention relates to substituted phenylcarbamate or naphthylcarbamate tricyclic compounds that provide highly potent and selective cholinergic agonist and blocking activity. These compounds are intended for use as pharmaceutical agents, offering improvements in therapy for cholinergic diseases such as glaucoma, Myasthenia Gravis, and Alzheimer's disease, as well as for organophosphate poisoning.
Career Highlights
Throughout his career, Rapoport has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. His work has significantly impacted the development of therapies for cognitive disorders.
Collaborations
Rapoport has collaborated with notable individuals in his field, including Arnold Brossi and Nigel H Greig. Their combined expertise has contributed to the advancement of research and innovation in cognitive health.
Conclusion
Stanley I Rapoport's work exemplifies the intersection of innovation and healthcare, particularly in addressing cognitive disorders. His patents and collaborations reflect a commitment to improving the lives of individuals affected by these conditions.